Chemoprevention meets glucose control - PubMed (original) (raw)
Comment
Chemoprevention meets glucose control
Jeffrey A Engelman et al. Cancer Prev Res (Phila). 2010 Sep.
Abstract
The report by Memmott et al. (beginning on page 1066 in this issue of the journal) assessing the efficacy of the antidiabetes drug metformin in a mouse model of lung carcinogenesis suggests protective effects via two possible avenues: Decreased circulating insulin and insulin-like growth factor levels and energy stress leading to inhibition of mammalian target of rapamycin signaling. These potential mechanisms are discussed in this perspective, as are their implications for cancer prevention and therapy.
Comment on
- Metformin prevents tobacco carcinogen--induced lung tumorigenesis.
Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA. Memmott RM, et al. Cancer Prev Res (Phila). 2010 Sep;3(9):1066-76. doi: 10.1158/1940-6207.CAPR-10-0055. Epub 2010 Sep 1. Cancer Prev Res (Phila). 2010. PMID: 20810672 Free PMC article.
Similar articles
- Teaching an old drug new tricks: metformin as a targeted therapy for lung cancer.
Antonoff MB, D'Cunha J. Antonoff MB, et al. Semin Thorac Cardiovasc Surg. 2010 Autumn;22(3):195-6. doi: 10.1053/j.semtcvs.2010.10.015. Semin Thorac Cardiovasc Surg. 2010. PMID: 21167452 - Metformin: diamonds are forever.
Papanas N, Maltezos E, Mikhailidis DP. Papanas N, et al. Expert Opin Pharmacother. 2009 Oct;10(15):2395-7. doi: 10.1517/14656560903176453. Expert Opin Pharmacother. 2009. PMID: 19678795 - Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI. Inzucchi SE, et al. N Engl J Med. 1998 Mar 26;338(13):867-72. doi: 10.1056/NEJM199803263381303. N Engl J Med. 1998. PMID: 9516221 Clinical Trial. - Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P, Barkin JS. Hookman P, et al. Am J Gastroenterol. 2003 Sep;98(9):2093-7. doi: 10.1111/j.1572-0241.2003.07670.x. Am J Gastroenterol. 2003. PMID: 14499793 Review. - Metformin for lung cancer prevention and improved survival: a novel approach.
Roos JF, Qudsi M, Samara A, Rahim MM, Al-Bayedh SA, Ahmed H. Roos JF, et al. Eur J Cancer Prev. 2019 Jul;28(4):311-315. doi: 10.1097/CEJ.0000000000000442. Eur J Cancer Prev. 2019. PMID: 29481337 Review.
Cited by
- The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma.
Jin W. Jin W. Front Cell Dev Biol. 2020 Jul 9;8:613. doi: 10.3389/fcell.2020.00613. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32754598 Free PMC article. Review. - From rapalogs to anti-aging formula.
Blagosklonny MV. Blagosklonny MV. Oncotarget. 2017 May 30;8(22):35492-35507. doi: 10.18632/oncotarget.18033. Oncotarget. 2017. PMID: 28548953 Free PMC article. Review. - Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase.
Oladimeji PO, Lin W, Brewer CT, Chen T. Oladimeji PO, et al. Sci Rep. 2017 Apr 24;7:46751. doi: 10.1038/srep46751. Sci Rep. 2017. PMID: 28436464 Free PMC article. - Metformin targets multiple signaling pathways in cancer.
Lei Y, Yi Y, Liu Y, Liu X, Keller ET, Qian CN, Zhang J, Lu Y. Lei Y, et al. Chin J Cancer. 2017 Jan 26;36(1):17. doi: 10.1186/s40880-017-0184-9. Chin J Cancer. 2017. PMID: 28126011 Free PMC article. Review. - Obesity and Cancer Mechanisms: Cancer Metabolism.
Hopkins BD, Goncalves MD, Cantley LC. Hopkins BD, et al. J Clin Oncol. 2016 Dec 10;34(35):4277-4283. doi: 10.1200/JCO.2016.67.9712. Epub 2016 Nov 7. J Clin Oncol. 2016. PMID: 27903152 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical